The Springboard Health Angels
Expert Group
Jens Noertershaeuser
Jens is co-founder and is Co-CEO of Kranus Health, a leader in virtual care for urology. Jens brings a decade of experience in pharmaceuticals and healthcare, focusing on digital transformation. He has held leadership roles at Palantir Technologies, Amazon, and McKinsey & Company, and holds an MBA from INSEAD and a Master’s in Bioengineering from KIT
Dr. Carl Firth
Carl is the CEO of ASLAN Pharmaceuticals, a US-listed biopharmaceutical company. With a background in commercial and R&D roles at AstraZeneca and healthcare investment banking at Bank of America Merrill Lynch, Carl also holds board positions at various biotechs and is an Adjunct Professor at Duke-NUS Medical School. He has a PhD in Computational Biology from Cambridge University
Yamila Eraso
Yamila is a partner at STUDIO LEGAL Rechtsanwälte, specializing in startup/venture financing, corporate governance, and cross-border business involving the U.S. and Latin America. Yamila is also an experienced angel investor and is admitted as a lawyer in Colombia and New York, and as a foreign attorney in Germany
Dr. Eric Yang
Eric is an experienced professional in drug development, utilizing ML/AI and other computational tools to efficiently retarget therapies to new patients. He has experience in drug development at major pharmaceutical companies such as J&J and Novartis as well as experience in the payor space at Aetna. Currently, he is at Medidata Solutions developing new ways of leveraging LLM and traditional ML methods in drug development